Literature DB >> 16080020

[Autoimmune neuropathies--current aspects of immunopathologic diagnostics and therapy].

R Gold1, A Bayas, K V Toyka.   

Abstract

The group of autoimmune neuropathies includes the Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuritis, multifocal motor neuropathy, neuropathies associated with monoclonal gammopathies, and vasculitic neuropathies. This educational review first addresses diagnostic pathways that facilitate more rational diagnostic decisions. Many therapies are effective for treating immune neuropathies. Unfortunately, none of the available therapies are specific. In the acute phase, glucocorticosteroids, plasmapheresis, and intravenous immunoglobulins play key roles. The list of long-term therapies includes azathioprine, cyclosporine, cyclophosphamide, and immunoglobulins. The therapeutic mechanisms involved are not clear for most of these compounds. Modern immunotherapy has to consider medical aspects, available therapeutic evidence, and long-term economic burden.

Entities:  

Mesh:

Year:  2005        PMID: 16080020     DOI: 10.1007/s00115-005-1942-5

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  23 in total

Review 1.  Animal models of immune-mediated neuropathies.

Authors:  Mathias Mäurer; Ralf Gold
Journal:  Curr Opin Neurol       Date:  2002-10       Impact factor: 5.710

Review 2.  Therapy of neurological disorders in systemic vasculitis.

Authors:  Ralf Gold; Adriano Fontana; Stephan Zierz
Journal:  Semin Neurol       Date:  2003-06       Impact factor: 3.420

Review 3.  Assessment of current diagnostic criteria for Guillain-Barré syndrome.

Authors:  A K Asbury; D R Cornblath
Journal:  Ann Neurol       Date:  1990       Impact factor: 10.422

4.  Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies.

Authors:  Susanne Renaud; Michael Gregor; Peter Fuhr; Delia Lorenz; Günther Deuschl; Alois Gratwohl; Andreas J Steck
Journal:  Muscle Nerve       Date:  2003-05       Impact factor: 3.217

Review 5.  Demyelinating inflammatory neuropathies, including Guillain-Barré syndrome.

Authors:  A J Steck; N Schaeren-Wiemers; H P Hartung
Journal:  Curr Opin Neurol       Date:  1998-08       Impact factor: 5.710

6.  Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study.

Authors:  A F Hahn; C F Bolton; N Pillay; C Chalk; T Benstead; V Bril; K Shumak; M K Vandervoort; T E Feasby
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

7.  Multifocal motor neuropathy presenting as chronic progressive proximal leg weakness.

Authors:  Mathias Mäurer; Guido Stoll; Klaus V Toyka
Journal:  Neuromuscul Disord       Date:  2004-06       Impact factor: 4.296

Review 8.  Immune-mediated components of hereditary demyelinating neuropathies: lessons from animal models and patients.

Authors:  Rudolf Martini; Klaus V Toyka
Journal:  Lancet Neurol       Date:  2004-08       Impact factor: 44.182

Review 9.  Multifocal motor neuropathy: diagnosis and treatment.

Authors:  A Pestronk
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

10.  Non-neural-specific T lymphocytes can orchestrate inflammatory peripheral neuropathy.

Authors:  G K Harvey; R Gold; H P Hartung; K V Toyka
Journal:  Brain       Date:  1995-10       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.